Open access
Sep 2026
A comparative real-world analysis of finerenone and steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
Background Finerenone and steroidal mineralocorticoid receptor antagonists (sMRAs) reduce proteinuria in chronic kidney disease (CKD), but direct comparative data from routine clinical practice remain limited. The objective of this study was to compare the effectiveness, hemodynamic effects, kidney function trajectory,...
D. Vetrano, Giuseppe Cianciolo, Simona Barbuto et al.
· Frontiers in Pharmacology · 0 citations